EUVIMEDEUVIMED entdecken
Übersichtsarbeit

How well are patient-reported outcomes reported in third molar randomized clinical trials? A meta-epidemiological evaluation of adherence to the CONSORT-PRO extension

Eduardo Frederico Eduardo Maferano, Paulo Ricardo Martins-Filho, Paulo Goberlânio de Barros Silva, Ana Flávia Granville-Garcia, Fábio Wildson Gurgel Costa

Journal of Cranio-Maxillofacial Surgery · 2026-04 · 54 (4) · 104466

DOI: 10.1016/j.jcms.2026.104466 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cranio-Maxillofacial Surgery, 2026-04. Verfasst von Eduardo Frederico Eduardo Maferano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, Faculty of Health Sciences, Zambeze University, Tete City, Mozambique; Postgraduate Program in Dentistry, Faculty of Dentist…. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Molar, Third, Patient Reported Outcome Measures, Guideline Adherence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This meta-epidemiological cross-sectional study assessed the adherence of randomized controlled trials (RCTs) on third molar surgery to the CONSORT-PRO extension and evaluated their risk of bias. A comprehensive search was performed across Medline via PubMed, EMBASE, CINAHL, PsycINFO, Cochrane Library, LILACS, Web of Science, Scopus, Epistemonikos, and Google Scholar. Parallel, crossover, and split-mouth RCTs that reported patient-reported outcomes (PROs) as primary or secondary endpoints were included. The primary outcome was the proportion of CONSORT-PRO items reported. Screening, data extraction, and assessments were independently performed by two reviewers. Of the 4220 records identified, 23 RCTs met the eligibility criteria. Overall adherence to CONSORT-PRO was low (mean = 45.6 %; SD = 8.9), with higher compliance among trials using PROs as primary outcomes (mean = 50.5 %; SD = 6.2) and lower when PROs were secondary (mean = 43.5 %; SD = 9.1). Approximately 43.5 % of trials presented some concerns regarding overall risk of bias. Adherence to CONSORT-PRO in RCTs on lower third molar surgery remains suboptimal, particularly when PROs are secondary outcomes. Strengthening methodological rigor and integrating CONSORT-PRO guidelines from trial design through reporting are essential to improve the quality, transparency, and reproducibility of patient-reported outcome data in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicMolar, ThirdPatient Reported Outcome MeasuresGuideline AdherenceHumansCross-Sectional Studies

Stichwörter der Autor:innen

CONSORT-PROMeta-epidemiologicalPatient-reported outcomeRandomized clinical trialsThird molars

Autor:innen und Institutionen

  • Department of Dentistry, Faculty of Health Sciences, Zambeze University, Tete City, Mozambique; Postgraduate Program in Dentistry, Faculty of Dentistry, Federal University of Ceará, Ceará, Fortaleza, Brazil. Electronic…
  • Investigative Pathology Laboratory, Federal University of Sergipe, Sergipe, Aracaju, Brazil.
  • Division of Oral Pathology, School of Dentistry, Christus University, Fortaleza, Ceará, Brazil; Postgraduate Program in Dentistry, Faculty of Dentistry, Federal University of Ceará, Ceará, Fortaleza, Brazil.
  • Postgraduate Program in Dentistry, State University of Paraíba, Campina Grande, Paraíba, Brazil.
  • Postgraduate Program in Dentistry, Faculty of Dentistry, Federal University of Ceará, Ceará, Fortaleza, Brazil.

Förderung

  • Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Maferano, E. F. E., Martins-Filho, P. R., de Barros Silva, P. G., Granville-Garcia, A. F., & Costa, F. W. G. (2026). How well are patient-reported outcomes reported in third molar randomized clinical trials? A meta-epidemiological evaluation of adherence to the CONSORT-PRO extension. Journal of Cranio-Maxillofacial Surgery, 54(4), 104466. https://doi.org/10.1016/j.jcms.2026.104466

Vancouver

Maferano EFE, Martins-Filho PR, de Barros Silva PG, Granville-Garcia AF, Costa FWG. How well are patient-reported outcomes reported in third molar randomized clinical trials? A meta-epidemiological evaluation of adherence to the CONSORT-PRO extension. Journal of Cranio-Maxillofacial Surgery. 2026;54(4):104466. doi:10.1016/j.jcms.2026.104466

BibTeX
@article{Maferano2026,
  author = {Maferano, Eduardo Frederico Eduardo and Martins-Filho, Paulo Ricardo and de Barros Silva, Paulo Goberlânio and Granville-Garcia, Ana Flávia and Costa, Fábio Wildson Gurgel},
  title = {How well are patient-reported outcomes reported in third molar randomized clinical trials? A meta-epidemiological evaluation of adherence to the CONSORT-PRO extension},
  journal = {Journal of Cranio-Maxillofacial Surgery},
  year = {2026},
  volume = {54},
  number = {4},
  pages = {104466},
  doi = {10.1016/j.jcms.2026.104466}
}
Kostenlos starten →